AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.
Legal status AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.
Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.
See also
5F-AB-PINACA 5F-ADB 5F-AMB 5F-APINACA AB-CHFUPYCA AB-FUBINACA AB-PINACA ADB-CHMINACA ADB-FUBINACA ADB-PINACA ADSB-FUB-187 AMB-FUBINACA APINACA MDMB-CHMICA MDMB-CHMINACA MDMB-FUBINACA PX-2 PX-3
References